1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Coeliac Disease: new trials by email Literature Review of Coeliac Disease trials Research Report on Coeliac Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease Amlitelimab, Placebo, SIGE - Coeliac Disease, Celiac Disease | Phase 2 | Active not recruiting | Sanofi | 229 | 2024-08-29 | 2026-08-31 |
| A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease KAN-101, Placebo - Celiac Disease, Coeliac Disease | Phase 2 | Completed | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 55 | 2023-12-13 | 2025-12-18 |
Celiac Disease (2)
Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Malabsorption Syndromes (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA (1) · Sanofi (1)
Canada (2) · Finland (2) · Germany (2) · Israel (2) · Netherlands (2) · Poland (2) · United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Chile (1) · Czechia (1) · France (1) · Greece (1)